Wednesday, February 22, 2012

Pneumococcal conjugated vaccine (pcv7) ...

vre bacteria

About pneumoniae or pneumococcus is a common cause of bacterial meningitis, sepsis and pneumonia. This bacterium is usually done in the back of the nose and throat and is spread from person to person through coughing, sneezing and close contact. Transmission and colonization can be harmless, however, pneumococcus can also lead to localized disease (such as ear infections, bronchitis), pneumonia (inflammation of the lungs, which sometimes invasive) or invasive disease, including sepsis (blood poisoning) and meningitis (infection of membranes around brain and spinal cord). Vulnerable populations including infants and young children, elderly, people with serious chronic diseases such as heart disease and diabetes, and those with impaired immunity, and certain ethnic groups such as Alaska and Native Americans. Since the 1980s, pneumococci have developed strattera price increasing resistance to antibiotics used to treat pneumococcal infections. It was more tempered with the introduction of pneumococcal conjugated vaccines for children, which prevents many drug-resistant pneumococcus serotypes. Warning In 2008, there are two vaccines to prevent infections due to pneumococcus


. Pneumococcal polysaccharide vaccine (PPV23) was introduced in 1983 and is recommended for all persons aged 65 and older, and for many young people with chronic diseases. Pneumococcal conjugated vaccine (PCV7), available since 2001, recommended for all children from age 2 months. For a more detailed schedule of vaccination recommendations, refer to published recommendations of the Advisory Committee on Immunization Practices (ACIP) or consult. Antibiotic prophylaxis is not recommended for close contacts pneumococcal disease patients, because the data do not confirm the effectiveness of this practice. More about.

No comments:

Post a Comment